Nuveen
NVCT icon

Nuveen’s Nuvectis Pharma NVCT Stock Holding History

Nuveen’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$751K Buy
40,823
+24,074
+144% +$270K ﹤0.01% 3089
2026
Q1 		$129K Hold
16,749
– – ﹤0.01% 3159
2025
Q4 		$126K Hold
16,749
– – ﹤0.01% 3197
2025
Q3 		$101K Hold
16,749
– – ﹤0.01% 3222
2025
Q2 		$125K Buy
+16,749
New +$152K ﹤0.01% 3236
2024
Q2 		– Sell
-11,883
Closed -$97.4K – 3390
2024
Q1 		$97.4K Hold
11,883
– – ﹤0.01% 3251
2023
Q4 		$99.1K Buy
11,883
+1,214
+11% +$10.8K ﹤0.01% 3287
2023
Q3 		$138K Hold
10,669
– – ﹤0.01% 3090
2023
Q2 		$170K Buy
+10,669
New +$170K ﹤0.01% 3115

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Nuveen's NVCT Position: Q2 2026 in Review

Nuveen increased its Nuvectis Pharma (NVCT) stake by 144% in Q2 2026, buying an estimated $270K and bringing the position to 40,823 shares worth $751K. The position accounts for ﹤0.01% of the portfolio, ranked #3089.

Nuveen first reported a position in NVCT in Q2 2023 and has held it in 9 quarters since. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Nuveen held 40,823 shares of Nuvectis Pharma worth $751K as of Q2 2026.
  • Nuveen bought 24,074 Nuvectis Pharma shares in Q2 2026, an estimated $270K.
  • Nuvectis Pharma made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3089 holding.
  • Nuveen first reported a position in Nuvectis Pharma in Q2 2023 and has held it in 9 quarters since.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.